61 related articles for article (PubMed ID: 19304323)
21. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity.
Johnson KD; Hsu AP; Ryu MJ; Wang J; Gao X; Boyer ME; Liu Y; Lee Y; Calvo KR; Keles S; Zhang J; Holland SM; Bresnick EH
J Clin Invest; 2012 Oct; 122(10):3692-704. PubMed ID: 22996659
[TBL] [Abstract][Full Text] [Related]
22. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies.
Bresnick EH; Katsumura KR; Lee HY; Johnson KD; Perkins AS
Nucleic Acids Res; 2012 Jul; 40(13):5819-31. PubMed ID: 22492510
[TBL] [Abstract][Full Text] [Related]
23. GATA2 mutations lead to MDS and AML.
Hyde RK; Liu PP
Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
[No Abstract] [Full Text] [Related]
24. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
[TBL] [Abstract][Full Text] [Related]
25. BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.
Perrotti D; Harb JG
Leuk Lymphoma; 2011 Feb; 52 Suppl 1(Suppl 1):30-44. PubMed ID: 21299458
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
27. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.
Nakayama H; Ishimaru F; Avitahl N; Sezaki N; Fujii N; Nakase K; Ninomiya Y; Harashima A; Minowada J; Tsuchiyama J; Imajoh K; Tsubota T; Fukuda S; Sezaki T; Kojima K; Hara M; Takimoto H; Yorimitsu S; Takahashi I; Miyata A; Taniguchi S; Tokunaga Y; Gondo H; Niho Y; Harada M
Cancer Res; 1999 Aug; 59(16):3931-4. PubMed ID: 10463586
[TBL] [Abstract][Full Text] [Related]
28. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
29. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
30. Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
Wihlidal P; Varga F; Pfeilstöcker M; Karlic H
Leuk Res; 2006 Oct; 30(10):1241-8. PubMed ID: 16387359
[TBL] [Abstract][Full Text] [Related]
31. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
Zhang SJ; Shi JY; Li JY
Leuk Res; 2009 Aug; 33(8):1141-3. PubMed ID: 19304323
[TBL] [Abstract][Full Text] [Related]
32. p53 gene alterations in human hematological malignancies: a review.
Soussi T; Jonveaux P
Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
[TBL] [Abstract][Full Text] [Related]
33. Chronic myeloid leukaemia as a model of disease evolution in human cancer.
Melo JV; Barnes DJ
Nat Rev Cancer; 2007 Jun; 7(6):441-53. PubMed ID: 17522713
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]